340B Experts Welcome HRSA’s Policy Clarifications on Hospital Child Sites and Telemedicine


Happy Thursday from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits

Read More »

EXCLUSIVE: HRSA Confirms 340B Hospital Offsite Location and Telehealth Flexibilities Are Permanent


Happy Tuesday from Publisher and CEO Ted Slafsky: In today’s issue, you will see a great piece on a little covered but important topic regarding the rights that covered entities have to resolve disputes with pharmaceutical

Read More »

Breaking News

BREAKING: HRSA Moves Forward on Plan To Allow for Expedited 340B Hospital Clinic Enrollment

SPONSORED BY

Read More »

HRSA Lifts Major Barrier to Using 340B Drugs at Hospital Offsite Locations


Happy Thursday from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. In

Read More »

Possibly Hundreds of Millions of Dollars Annually in Lost 340B Savings Draw Closer in California


A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click

Read More »

The CMS 340B Drug Cost Survey Is a Wrap. So, What Happens Now?


Editor’s note: Our next regularly scheduled edition will be on Thursday, May 28 due to the Memorial Day holiday weekend. We’ll publish an extra edition for any breaking news.

A note from 340B Report Publisher and

Read More »

Two More National Hospitals Groups Urge CMS to Stop 340B Drug Cost Survey


A note from 340B Report CEO and Publisher Ted Slafsky: Today’s issue includes the fourth in our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below

Read More »

Largest Hospital Group to CMS: 340B Drug Survey Is Burdensome, Ill-Timed, Illegal


A note from 340B Report CEO and Publisher Ted Slafsky: Today’s issue includes the third in our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below

Read More »

The COVID-19 Pandemic Is No Time for a 340B Drug Cost Survey, Hospitals Say

A Note from 340B Report CEO and Publisher Ted Slafsky

We hope you are enjoying 340B Report. We are grateful for the positive feedback and excited that thousands

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer